Benjamin F. Edwards & Company’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $812K | Buy |
16,737
+4,207
| +34% | +$203K | 0.01% | 580 |
|
|
2024
Q1 | $609K | Buy |
12,530
+3,320
| +36% | +$162K | 0.01% | 620 |
|
|
2023
Q4 | $458K | Buy |
9,210
+6,989
| +315% | +$342K | 0.01% | 655 |
|
|
2023
Q3 | $119K | Buy |
2,221
+376
| +20% | +$20K | ﹤0.01% | 855 |
|
|
2023
Q2 | $99K | Sell |
1,845
-15
| -0.8% | -$807 | ﹤0.01% | 908 |
|
|
2023
Q1 | $101K | Sell |
1,860
-75
| -4% | -$3.65K | ﹤0.01% | 908 |
|
|
2022
Q4 | $94K | Sell |
1,935
-172
| -8% | -$7.55K | ﹤0.01% | 921 |
|
|
2022
Q3 | $80K | Sell |
2,107
-2,178
| -51% | -$97.1K | ﹤0.01% | 931 |
|
|
2022
Q2 | $214K | Sell |
4,285
-79
| -2% | -$4.19K | 0.01% | 655 |
|
|
2022
Q1 | $224K | Buy |
4,364
+163
| +4% | +$8.42K | 0.01% | 654 |
|
|
2021
Q4 | $210K | Sell |
4,201
-940
| -18% | -$46.5K | 0.01% | 673 |
|
|
2021
Q3 | $248K | Sell |
5,141
-105
| -2% | -$5.34K | 0.01% | 605 |
|
|
2021
Q2 | $276K | Buy |
5,246
+143
| +3% | +$7.46K | 0.01% | 576 |
|
|
2021
Q1 | $252K | Sell |
5,103
-80
| -2% | -$3.84K | 0.01% | 619 |
|
|
2020
Q4 | $252K | Buy |
5,183
+439
| +9% | +$21.7K | 0.02% | 579 |
|
|
2020
Q3 | $238K | Sell |
4,744
-181
| -4% | -$9.32K | 0.02% | 553 |
|
|
2020
Q2 | $251K | Sell |
4,925
-191
| -4% | -$9.28K | 0.02% | 517 |
|
|
2020
Q1 | $224K | Sell |
5,116
-29
| -0.6% | -$1.39K | 0.02% | 493 |
|
|
2019
Q4 | $258K | Sell |
5,145
-651
| -11% | -$30.5K | 0.02% | 542 |
|
|
2019
Q3 | $269K | Sell |
5,796
-196
| -3% | -$8.45K | 0.02% | 489 |
|
|
2019
Q2 | $259K | Buy |
5,992
+78
| +1% | +$3.32K | 0.02% | 476 |
|
|
2019
Q1 | $262K | Sell |
5,914
-908
| -13% | -$38.9K | 0.02% | 461 |
|
|
2018
Q4 | $296K | Sell |
6,822
-158
| -2% | -$6.97K | 0.03% | 401 |
|
|
2018
Q3 | $312K | Sell |
6,980
-1,800
| -21% | -$76.9K | 0.03% | 429 |
|
|
2018
Q2 | $351K | Sell |
8,780
-4,811
| -35% | -$189K | 0.03% | 390 |
|
|
2018
Q1 | $545K | Buy |
13,591
+1,075
| +9% | +$44.7K | 0.06% | 313 |
|
|
2017
Q4 | $538K | Sell |
12,516
-2,347
| -16% | -$108K | 0.06% | 303 |
|
|
2017
Q3 | $740K | Sell |
14,863
-350
| -2% | -$16.9K | 0.09% | 225 |
|
|
2017
Q2 | $729K | Sell |
15,213
-5,610
| -27% | -$268K | 0.1% | 212 |
|
|
2017
Q1 | $942K | Sell |
20,823
-5,685
| -21% | -$241K | 0.14% | 163 |
|
|
2016
Q4 | $1.07M | Sell |
26,508
-13,495
| -34% | -$532K | 0.18% | 137 |
|
|
2016
Q3 | $1.53M | Sell |
40,003
-800
| -2% | -$32.1K | 0.27% | 88 |
|
|
2016
Q2 | $1.71M | Buy |
40,803
+1,540
| +4% | +$63.1K | 0.33% | 75 |
|
|
2016
Q1 | $1.58M | Buy |
39,263
+4,861
| +14% | +$195K | 0.33% | 70 |
|
|
2015
Q4 | $1.47M | Sell |
34,402
-4,186
| -11% | -$193K | 0.32% | 74 |
|
|
2015
Q3 | $1.83M | Buy |
38,588
+13,459
| +54% | +$685K | 0.4% | 59 |
|
|
2015
Q2 | $1.25M | Buy |
25,129
+11,492
| +84% | +$582K | 0.25% | 89 |
|
|
2015
Q1 | $674K | Buy |
13,637
+9,840
| +259% | +$470K | 0.14% | 157 |
|
|
2014
Q4 | $173K | Buy |
3,797
+550
| +17% | +$26.7K | 0.04% | 319 |
|
|
2014
Q3 | $183K | Sell |
3,247
-100
| -3% | -$5.37K | 0.05% | 315 |
|
|
2014
Q2 | $178K | Buy |
3,347
+75
| +2% | +$3.98K | 0.05% | 309 |
|
|
2014
Q1 | $171K | Sell |
3,272
-800
| -20% | -$40.5K | 0.05% | 296 |
|
|
2013
Q4 | $218K | Buy |
4,072
+400
| +11% | +$20.6K | 0.07% | 232 |
|
|
2013
Q3 | $186K | Buy |
3,672
+155
| +4% | +$7.89K | 0.07% | 235 |
|
|
2013
Q2 | $181K | Buy |
+3,517
| New | +$187K | 0.07% | 226 |
|
Other funds holding SNY
Benjamin F. Edwards & Company's SNY Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Sanofi (SNY) stake by 34% in Q2 2024, buying an estimated $203K and bringing the position to 16,737 shares worth $812K. The position accounts for 0.01% of the portfolio, ranked #580.
Benjamin F. Edwards & Company first reported a position in SNY in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.83M in Q3 2015. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.
- Benjamin F. Edwards & Company held 16,737 shares of Sanofi worth $812K as of Q2 2024.
- Benjamin F. Edwards & Company bought 4,207 Sanofi shares in Q2 2024, an estimated $203K.
- Sanofi made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #580 holding.
- Benjamin F. Edwards & Company first reported a position in Sanofi in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's Sanofi position peaked at $1.83M in Q3 2015.
- 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.